When analysing mergers which risk generating anti-competitive effects, competition agencies often consider the trade-off between prohibiting the transaction and granting a conditional clearance. While it is clear that agencies should establish that a transaction generates anti-competitive effects to either prohibit it or impose conditions to its clearance, the point beyond which sufficient harm is assumed to be established, and a prohibition decision or the imposition of remedies are justified, is not always clear. In November 2016, the OECD held a roundtable to explore competition authorities’ approaches to prohibiting mergers or accepting remedies to achieve a conditional clearance. The discussion provided insights into the factors that competition authorities consider when making their decision. Read the detailed summary of the discussion • Voir le compte rendu détaillé de la discussion |
NOVEMBER 2016 SESSION DOCUMENTATION | ||
Key documents and panellists information » Executive summary with key findings • Synthèse et points cléfs » Detailed summary of discussion • Compte rendu détaillé de la discussion » Background Note by the OECD Secretariat • Note de Référence du Secrétariat Panellists Nicholas LEVY Bio Paula RIEDEL Bio
|
Contributions from participants |
|
PRESENTATIONS
RELATED POLICY ROUNDTABLES Remedies in cross-border merger cases, 2013 Impact evaluation of merger decisions, 2011 Remedies in merger cases, 2011
|
|
Documents connexes